20 November 2017
News and Views
Links and Services
A study published in advance in this week's Lancet investigates lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease.
Reports of an increased risk of lymphoproliferative disorders in patients receiving thiopurines f
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors